In an effort to support the 42 million caregivers in the U.S. who are caring for parents and older loved ones and to illustrate the complexity of this relationship, AARP and the Ad Council are unveiling a new suite of public service advertisements (PSAs), including ads specifically designed to reach the Hispanic community, as an extension of their national Caregiver Assistance campaign. The PSAs, which launch today alongside new data highlighting the added stressors many caregivers face during the holiday, will be distributed to media outlets this week to coincide with National Family Caregivers Month (November).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7366551-aarp-ad-council-caregiver-psa-s-tools-resources/
SAIC, Inc. (NYSE: SAI) today held an Investor Day event in New York City in which the senior leadership team of the planned spin-off company, Science Applications International Corp. (SAIC), presented its business plans and financial objectives.
SAIC, Inc. previously announced plans to create two independent, publicly traded companies. Upon completion of the planned spin-off transaction, the technical, engineering and enterprise IT services business will retain the name SAIC and trade under (NYSE: SAIC), while the government and commercial solutions company will be named Leidos and trade under (NYSE: LDOS).
To view Multimedia News Release, go to http://www.multivu.com/mnr/63326-saic-presents-planned-company-s-business-financial-objectives-investor-day
Corporate cyber-attacks cost the global economy hundreds of billions of dollars annually. Recent, high-visibility data breaches underscore the need for advanced cyber-security defenses, particularly in the financial services sector. Corporate boards and senior risk executives are taking notice, resulting in a surge in demand for qualified candidates to take on a new C-suite role: the Chief Information Security Officer (CISO).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7245051-heidrick-and-struggles-debuts-leadershiptv-insights-cyber-attacks-for-c-suite/
Barrister, peer and Vice-President of the Patients Association Baroness Helena Kennedy has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7424051-helena-kennedy-astellas-debate/
The American Society for Aesthetic Plastic Surgery (ASAPS) released its complete 18th annual multi-specialty statistical data today showing an aesthetic plastic surgery spend consistent with the figures for 2013, with Americans spending more than 12 billion dollars on surgical and nonsurgical procedures for the second year in a row. With more than 10 million cosmetic procedures performed in 2014, those that showed the largest growth in volume on a year-over-year basis included buttock augmentation (up 86%), labiaplasty (up 49%), and nonsurgical fat reduction (up 42%). Additionally, more men are turning to aesthetic cosmetic procedures, with dramatic increases seen in both surgical and nonsurgical options over the past 5 years and a 43% increase overall.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7310751-asaps-2014-plastic-surgery-trends/
The last year saw many achievements for Chengdu’s meetings, incentives, conferences and exhibitions (MICE) industry. According to data from the Chengdu Municipal Statistics Bureau, Chengdu hosted 530 major exhibitions, conferences and forums in 2014, of which 214 were exhibitions, 45 more than a year earlier or a year-over-year (YOY) growth rate of 26.6 percent, and 113 were international conferences and forums, 8 more than a year earlier, or a YOY growth rate of 7.6 percent. The events took up 3.25 million square meters of space in the aggregate, a YOY growth rate of 8.0 percent, of which 49 were international in nature, occupying 1.74 million square meters, a YOY growth rate of 16.0 percent. Direct revenue derived from the industry for 2014 totaled 6.95 billion yuan, up 14.9 percent year-on-year while overall revenue (direct plus indirect) revenue reached 58.4 billion yuan, up 14.5 percent year-on-year.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7511651-chengdu-china-mice-industry/
France remains the top destination for their North American travelers according to Rail Europe, Inc., the largest distributor of European rail products in North America. According to sales data, Italy and the United Kingdom followed France respectively as the top destinations for Rail Europe travelers this summer.
In reviewing their 2014 sales figures, Rail Europe identified noteworthy travel data that showcases the latest trends and preferences among their North American clients.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7157831-rail-europe-inc-newsroom/
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
NOAA’s Joint Polar Satellite System-1 (JPSS-1) is encapsulated inside the fairing (nose cone) of a United Launch Alliance Delta II launch vehicle ready for lift off from Space Launch Complex-2W at Vandenberg Air Force Base, California, on November 14, 2017 at 1:47 a.m., PST. JPSS-1 is a collaborative effort between NOAA and NASA.
“The JPSS-1 bus is based on our Ball Configurable Platform 2000, a proven, agile spacecraft, which has 50 years of on-orbit operations and is designed for cost-effective, remote sensing applications,” said Alex Chernushin, JPSS-1 Program Manager, Ball Aerospace. “JPSS-1 is the twelfth spacecraft built on this core architecture, including the Suomi National Polar-orbiting Partnership (Suomi NPP) spacecraft launched in 2011.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7987651-ball-aerospace-joint-polar-satellite-system-jpss-1-launch/
GE Transportation continues to harness the power of the Industrial Internet for its rail customers, while it strengthens their local economies with partnership and investment for localized manufacturing capabilities of locomotives and other rail technologies.
PowerHaul locomotives are among the most technologically advanced, fuel-efficient and low-emissions, diesel-electric locomotives in GE's fleet. Launched at InnoTrans in 2010, it has become a global platform for GE and is currently serving the United Kingdom, Korea, Australia, Europe and Turkey. Designed for high-haulage capability with lighter axle-load applications, the PowerHaul locomotive is engineered to generate more horsepower and tractive effort while lowering fuel consumption and greenhouse gas (GHG) emissions.
To see the Multimedia News Release, go to: http://www.multivu.com/players/English/7318451-ge-transportation-locomotives-data-driven-signaling-rail-operation-optimization-technology-on-display-at-innotrans-2014/
L’accession chez Nexity représente 46,6% de nos clients particuliers (– 1,3 point par rapport au point haut des 9 mois 2013). En volume, elle est en retrait de 7,9% par rapport aux 9 mois 2013.
Près de la moitié de l’activité en résidence principale se concentre en zone A (47%, en hausse de 6 points), au détriment de la zone B2 qui recule de 5 points (7%). Au total, les zones A bis et A représentent 63% des ventes en accession.
Les budgets moyens sont en baisse dans toutes les zones et pour tous les profils : celui des primo-accédants recule de 2,1%, à 223 k€ et celui des déjà-propriétaires de 4,5%, à 341 k€.
Pour visualiser le communiqué multimédia, rendez-vous sur: http://www.multivu.com/players/English/72762579-nexity-conjoncture-logement
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
